On September 10, 2026, Tandem Diabetes Care Inc TNDM shares fell 4.2% to a current price of $18.31. The stock has experienced notable volatility, trading between a 52-week high of $29.65 and a low of $11.46. The recent price dip adds to a challenging trend over the past month, with a decline of 19.7%.
- GF Valueâ„¢ verdict: Currently priced at $18.31, TNDM is estimated to be 23.9% undervalued compared to a GF Valueâ„¢ of $24.07.
- GF Scoreâ„¢ of 69/100 indicates the stock is considered above average, reflecting a mixed performance across various metrics.
- Insider activity has been stagnant, with no buying or selling by insiders over the past 12 months.
Is TNDM Overvalued or Undervalued?
The current market price of Tandem Diabetes Care Inc TNDM at $18.31 is significantly below the GF Valueâ„¢ estimate of $24.07, indicating a potential upside of 23.9%. GF Valueâ„¢ represents GuruFocus' proprietary intrinsic-value estimate, derived from analyzing historical trading multiples, past business growth, and projected future performance. However, caution is warranted, as the GF Valueâ„¢ metric can be less reliable for companies that are unprofitable or cash-flow negative, such as TNDM.
TNDM's current financial situation raises concerns about its valuation. As a company that has not achieved profitability, relying on earnings-based metrics like P/E is not applicable. Instead, the Price-to-Sales (P/S) ratio becomes more relevant. Currently, TNDM is trading well below its historical median P/S ratio of approximately 3.2x, suggesting a potential opportunity for value investors. However, the company's financial strength rating is low at 3/10, indicating that risks remain high, making it critical for potential investors to assess these factors carefully.
How Does TNDM's Valuation Compare to Its History?
| Metric | Current | Historical |
|---|---|---|
| P/E (TTM) | N/A | 509.4x (5-Year Median) |
| Forward P/E | 126.3x | N/A |
As TNDM does not currently have a valid trailing P/E due to its unprofitability, this analysis leans heavily on the forward P/E of 126.3x, which is significantly lower than its historical median of 509.4x. This disparity reflects the company's current financial difficulties and supports a view that the stock is potentially undervalued relative to its historical performance. However, this conclusion is complicated by the lack of earnings, which makes traditional valuation methods less applicable.
What Does TNDM's GF Scoreâ„¢ Tell Us?
GF Scoreâ„¢ is a comprehensive measure that evaluates a company's performance across multiple dimensions, including financial strength, profitability, growth, valuation, and momentum. TNDM's GF Scoreâ„¢ of 69/100 indicates above-average potential, although this score masks significant weaknesses in certain areas.
| Metric | Rating |
|---|---|
| GF Scoreâ„¢ | 69 |
| Financial Strength | 3/10 |
| Profitability | 3/10 |
| Growth | 6/10 |
| Valuation | 8/10 |
| Momentum | 10/10 |
The strongest aspect of TNDM's score lies in its momentum, earning a perfect 10/10. However, the company struggles significantly in financial strength and profitability, both rated at 3/10. These contrasting scores highlight a company that may be experiencing positive short-term trends but lacks the foundational financial metrics that would typically support a strong investment case.
What Are Gurus and Insiders Doing with TNDM?
As of the latest data, five gurus currently hold positions in TNDM, with all five having added to their positions in recent quarters. This indicates a level of confidence among some professional investors, which can be a positive sign for the stock's future. However, it's worth noting that there has been no insider buying or selling activity over the past 12 months, suggesting that insiders may not have confidence in the stock's immediate prospects.
The lack of insider transactions could be interpreted as a lack of conviction among those closest to the company. In the context of guru activity, while the addition of positions by multiple gurus is encouraging, the absence of insider buying might temper enthusiasm and requires further scrutiny of the stock's long-term prospects.
What This Means for Investors
Based on the current analysis, TNDM appears to be undervalued according to GF Valueâ„¢, which estimates a fair value of $24.07 against the current $18.31 price. However, the underlying risks associated with its unprofitability and low financial strength ratings should not be overlooked. Investors should consider these factors carefully before making investment decisions. For more detailed insights, visit the Tandem Diabetes Care Inc TNDM stock page and explore the GF Valueâ„¢ page for additional information.
Frequently Asked Questions
What is TNDM's GF Scoreâ„¢?
TNDM has a GF Scoreâ„¢ of 69/100, indicating that it is considered to have above-average potential based on various performance metrics.
Is TNDM overvalued or undervalued?
According to GF Valueâ„¢, TNDM is currently undervalued, with a fair value estimate of $24.07 compared to its current price of $18.31.
What is TNDM's P/E ratio?
TNDM does not currently have a valid trailing P/E ratio due to its unprofitability; however, its forward P/E is 126.3x, which is significantly lower than its 5-year median of 509.4x.
This stock alert was generated using automated technology and GuruFocus financial data to provide readers with timely and accurate market reporting. This content was reviewed by GuruFocus editorial team prior to publication. Please send any questions or comments about this story to [email protected].
